Biotech Values

[DewDiligence]

AEGR adds BoD member from Sarissa Capital:

http://finance.yahoo.com/news/aegerion-pharmaceuticals-reaches-agreement-sarissa-123000532.html

Under the terms of the agreement, the Company is appointing a new independent director to its Board of Directors identified by Sarissa and agreed upon by the Company. With such addition, the Board will increase from seven to eight directors, seven of whom are independent. Sarissa will also have the option to appoint an additional director beginning in January 2016. As part of the agreement, Sarissa has agreed to certain standstill provisions, and has agreed to vote in favor of all nominees recommended by the Board at the 2015 Annual Meeting of Stockholders.